Thermo Fisher Scientific, Inc. will be the premier sponsor for the inaugural Applied Pharmaceutical Analysis (APA) conference to be hosted in India.
Thermo Fisher Scientific, Inc. will be the premier sponsor for the inaugural Applied Pharmaceutical Analysis (APA) conference to be hosted in India. The conference will showcase the latest pharmaceutical research and development technologies and will feature topics in discovery and regulated bioanalysis, biotransformation, and process chemistry. The conference will be held at the Hyderabad International Convention Centre in Hyderabad, India, February 21 - 24, 2010."We are excited to be an integral part of such an important conference which will bring together the scientific communities and technologies from around the world to advance pharmaceutical research and development on a global scale. These collaborations will enable us to continually address the challenges faced by the pharmaceutical industry today, as well as anticipate and prepare for the needs of the future," states Koos van der Steuijt, country leader at Thermo Fisher Scientific in Mumbai, India.
Thermo Fisher will feature several new systems, including their newest LIMS offering, which they report will enable direct data acquisition, peak integration and re-integration, storage, archiving, and reporting of raw data. Their market for the systems is top 20 pharmaceutical companies as well as leading clinical research organizations (CROs) worldwide.
An Interview with AES Mid-Career Award Recipient Jason Dwyer
July 25th 2024Jason Dwyer of the University of Rhode Island has been named the recipient of the American Electrophoresis Society’s Mid-Career Award, which honors exceptional contributions to the field of electrophoresis, microfluidics, and related areas by an individual who is currently in the middle of their career.
Glucose's Impact on Brain Cancer Cells Unveiled Through Raman Imaging
July 25th 2024Researchers have used Raman spectroscopy and chemometric methods to reveal how glucose affects normal and cancerous brain cell metabolism. Their findings highlight specific biomarkers that can distinguish metabolic changes, potentially aiding in cancer research and treatment.